Validation and optimization of smart eye camera as teleophthalmology device for the reduction of preventable and treatable blindness in Nigeria
Eye · 2025
DOI: 10.1038/s41433-024-03489-0 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Eye, 2025. Verfasst von Ayodele Jacob Orugun und 12 weiteren Autor:innen. Beteiligte Einrichtung: ECWA Eye Hospital, Kano, Kano State, Nigeria. ayorugun@yahoo.com. Hauptthemen laut MEDLINE: Blindness, Telemedicine, Ophthalmology, Photography. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/OBJECTIVES: Limited resources and staffing hinders efforts to reduce preventable blindness, especially in low- to middle-income countries. The slit-lamp examination (SLE), which is essential for ophthalmology practices, is often unavailable in primary and secondary eye care facilities due to the high costs and lengthy training required for operation. We conducted a cross-sectional, multicentre study exploring the potential for a smart eye camera (SEC; a tele-ophthalmology handheld device developed by OUI Inc., Japan) to address the limitations of the SLE. SUBJECT/METHODS: Ocular diagnoses, visual acuity assessments and examinations of the eyes were performed independently using both a conventional SLE and a SEC. Four independent assessors (blind to the study) reviewed the images captured by the SEC and the SLE as administered by separate investigators. All analyses were performed using R version 4.2.2 for macOS at a 5% level of statistical significance. RESULTS: The results of the image quality analysis demonstrated that the number of higher-quality images was significantly higher (p < 0.05) for the images captured using the SEC device compared to the SLE machine. Remarkably, up to 96% accuracy of diagnosis was recorded with SEC. Evaluation of diagnostic accuracy rates derived from images obtained from both machines revealed a degree of divergence in assessments among evaluators, yielding a Fleiss's Kappa value of 0.092. The sensitivity analysis for the SEC device revealed a reasonably strong capacity to correctly identify true positive cases, with an average sensitivity score of 90%. CONCLUSION: The results of this study indicate that SEC can effectively evaluate anterior segment lesions in ophthalmology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- ECWA Eye Hospital, Kano, Kano State, Nigeria. ayorugun@yahoo.com.
- ECWA Eye Hospital, Kano, Kano State, Nigeria.
- Department of Ophthalmology, Faculty of Clinical Sciences, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria.
- UNESCO-International Center for Biotechnology, Nsukka, 410001, Enugu State, Nigeria.
- OUI Inc., Tokyo, Japan.
- Yokohama Keiai Eye Clinic, Yokohama, Japan.
Zitieren
APA
Orugun, A. J., Atima, M. O., Idakwo, U., Komolafe, O., Oladigbolu, K. K., Peter, E., Abdulsalam, H. O., Atima-Ayeni, E., Dingwoke, E. J., Khemlani, R., Nakayama, S., Shimizu, E., & Balogun, E. O. (2025). Validation and optimization of smart eye camera as teleophthalmology device for the reduction of preventable and treatable blindness in Nigeria. Eye. https://doi.org/10.1038/s41433-024-03489-0
Vancouver
Orugun AJ, Atima MO, Idakwo U, Komolafe O, Oladigbolu KK, Peter E, et al. Validation and optimization of smart eye camera as teleophthalmology device for the reduction of preventable and treatable blindness in Nigeria. Eye. 2025. doi:10.1038/s41433-024-03489-0
BibTeX
@article{Orugun2025,
author = {Orugun, Ayodele Jacob and Atima, Mayor Orezime and Idakwo, Ugbede and Komolafe, Oyeronke and Oladigbolu, Kehinde Kabir and Peter, Elijah and Abdulsalam, Halima Olufunmilola and Atima-Ayeni, Emamoke and Dingwoke, Emeka John and Khemlani, Rohan and Nakayama, Shintaro and Shimizu, Eisuke and Balogun, Emmanuel Oluwadare},
title = {Validation and optimization of smart eye camera as teleophthalmology device for the reduction of preventable and treatable blindness in Nigeria},
journal = {Eye},
year = {2025},
doi = {10.1038/s41433-024-03489-0}
}
EUVIMED